Savara Inc - Asset Resilience Ratio

Latest as of December 2025: 79.91%

Savara Inc (SVRA) has an Asset Resilience Ratio of 79.91% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$202.52 Million

Cash + Short-term Investments

Total Assets

$253.44 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Savara Inc's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Savara Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Savara Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Savara Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$202.52 Million	79.91%
Total Liquid Assets	$202.52 Million	79.91%

Asset Resilience Insights

Very High Liquidity: Savara Inc maintains exceptional liquid asset reserves at 79.91% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Savara Inc Industry Peers by Asset Resilience Ratio

Compare Savara Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Akero Therapeutics Inc NASDAQ:AKRO	Biotechnology	55.87%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Immunitybio Inc NASDAQ:IBRX	Biotechnology	38.07%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Savara Inc (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Savara Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	79.91%	$202.52 Million	$253.44 Million	-5.21pp
2024-12-31	85.12%	$181.20 Million	$212.88 Million	+8.68pp
2023-12-31	76.44%	$135.73 Million	$177.56 Million	+23.66pp
2022-12-31	52.78%	$73.78 Million	$139.78 Million	-19.22pp
2021-12-31	72.00%	$127.16 Million	$176.60 Million	+11.33pp
2020-12-31	60.68%	$59.31 Million	$97.75 Million	+7.85pp
2019-12-31	52.83%	$71.96 Million	$136.20 Million	-3.99pp
2018-12-31	56.82%	$86.53 Million	$152.29 Million	+11.59pp
2017-12-31	45.23%	$72.19 Million	$159.63 Million	+35.76pp
2016-12-31	9.47%	$2.74 Million	$28.93 Million	-23.60pp
2015-12-31	33.07%	$17.93 Million	$54.22 Million	+2.60pp
2014-12-31	30.47%	$21.48 Million	$70.50 Million	-3.40pp
2013-12-31	33.87%	$18.71 Million	$55.25 Million	+4.04pp
2012-12-31	29.83%	$14.01 Million	$46.97 Million	+18.30pp
2011-12-31	11.53%	$7.13 Million	$61.86 Million	-42.55pp
2007-12-31	54.09%	$18.68 Million	$34.54 Million	+5.28pp
2006-12-31	48.81%	$25.77 Million	$52.80 Million	+15.12pp
2005-12-31	33.69%	$7.96 Million	$23.62 Million	--

pp = percentage points

About Savara Inc

NASDAQ:SVRA USA Biotechnology

Market Cap

$1.12 Billion

Market Cap Rank

#8557 Global

#2462 in USA

Share Price

$5.46

Change (1 day)

-1.44%

52-Week Range

$2.57 - $6.94

All Time High

$45.57